Jennifer Kamocsay
Algemeen Adviseur bij AKOYA BIOSCIENCES, INC.
Vermogen: 379 009 $ op 30-04-2024
Profiel
Jennifer Kamocsay is currently the General Counsel at Akoya Biosciences, Inc. She previously worked as the Associate General Counsel at Progress Software Corp.
and as the General Counsel at Rubius Therapeutics, Inc. Ms. Kamocsay received an undergraduate degree from the University of California and a graduate degree from Northeastern University School of Law.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
AKOYA BIOSCIENCES INC
0.20% | 01-03-2024 | 99 217 ( 0.20% ) | 379 009 $ | 30-04-2024 |
Actieve functies van Jennifer Kamocsay
| Bedrijven | Functie | Begin |
|---|---|---|
| AKOYA BIOSCIENCES, INC. | Algemeen Adviseur | 28-02-2023 |
Eerdere bekende functies van Jennifer Kamocsay
| Bedrijven | Functie | Einde |
|---|---|---|
| PROGRESS SOFTWARE CORPORATION | Corporate Officer/Principal | - |
| RUBIUS THERAPEUTICS | Algemeen Adviseur | - |
Opleiding van Jennifer Kamocsay
| University of California | Undergraduate Degree |
| Northeastern University School of Law | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| AKOYA BIOSCIENCES, INC. | Health Technology |
| PROGRESS SOFTWARE CORPORATION | Technology Services |
| Bedrijven in privébezit | 1 |
|---|---|
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA. | Health Technology |
